The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hemoperfusion Production Market Research Report 2025
Synopsis
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.
The global Hemoperfusion Production market was valued at US$ 574 million in 2023 and is anticipated to reach US$ 1582.2 million by 2030, witnessing a CAGR of 15.4% during the forecast period 2024-2030.
Global Hemoperfusion Production key players include Baxter (Gambro), Jafron Biomedical, Biosun Medical, Asahi-Kasei, etc. Global top four manufacturers hold a share over 80%.
China is the largest market, with a share over 65%, followed by Europe, and Japan, both have a share about 30 percent.
In terms of product, Resin Adsorption is the largest segment, with a share over 65%. And in terms of application, the largest application is Hepatic Encephalopathy, followed by Certain Autoimmune Diseases, Overdose, Specific Intoxications, etc.
This report aims to provide a comprehensive presentation of the global market for Hemoperfusion Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion Production.
Report Scope
The Hemoperfusion Production market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemoperfusion Production market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemoperfusion Production manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jafron Biomedical
Baxter (Gambro)
Biosun Medical
Toray Medical
Asahi-Kasei
Kaneka
Zibo Kangbei
Aier
Cytosorbents
Segment by Type
Resin Adsorption
Activated Carbon Adsorption
Others
Segment by Application
Overdose
Specific Intoxications
Certain Autoimmune Diseases
Hepatic Encephalopathy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemoperfusion Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemoperfusion Production in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.
The global Hemoperfusion Production market was valued at US$ 574 million in 2023 and is anticipated to reach US$ 1582.2 million by 2030, witnessing a CAGR of 15.4% during the forecast period 2024-2030.
Global Hemoperfusion Production key players include Baxter (Gambro), Jafron Biomedical, Biosun Medical, Asahi-Kasei, etc. Global top four manufacturers hold a share over 80%.
China is the largest market, with a share over 65%, followed by Europe, and Japan, both have a share about 30 percent.
In terms of product, Resin Adsorption is the largest segment, with a share over 65%. And in terms of application, the largest application is Hepatic Encephalopathy, followed by Certain Autoimmune Diseases, Overdose, Specific Intoxications, etc.
This report aims to provide a comprehensive presentation of the global market for Hemoperfusion Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion Production.
Report Scope
The Hemoperfusion Production market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemoperfusion Production market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemoperfusion Production manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jafron Biomedical
Baxter (Gambro)
Biosun Medical
Toray Medical
Asahi-Kasei
Kaneka
Zibo Kangbei
Aier
Cytosorbents
Segment by Type
Resin Adsorption
Activated Carbon Adsorption
Others
Segment by Application
Overdose
Specific Intoxications
Certain Autoimmune Diseases
Hepatic Encephalopathy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemoperfusion Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemoperfusion Production in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hemoperfusion Production Market Overview
1.1 Product Overview and Scope of Hemoperfusion Production
1.2 Hemoperfusion Production Segment by Type
1.2.1 Global Hemoperfusion Production Market Value Comparison by Type (2024-2030)
1.2.2 Resin Adsorption
1.2.3 Activated Carbon Adsorption
1.2.4 Others
1.3 Hemoperfusion Production Segment by Application
1.3.1 Global Hemoperfusion Production Market Value by Application: (2024-2030)
1.3.2 Overdose
1.3.3 Specific Intoxications
1.3.4 Certain Autoimmune Diseases
1.3.5 Hepatic Encephalopathy
1.3.6 Others
1.4 Global Hemoperfusion Production Market Size Estimates and Forecasts
1.4.1 Global Hemoperfusion Production Revenue 2019-2030
1.4.2 Global Hemoperfusion Production Sales 2019-2030
1.4.3 Global Hemoperfusion Production Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemoperfusion Production Market Competition by Manufacturers
2.1 Global Hemoperfusion Production Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hemoperfusion Production Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hemoperfusion Production Average Price by Manufacturers (2019-2024)
2.4 Global Hemoperfusion Production Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemoperfusion Production, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemoperfusion Production, Product Type & Application
2.7 Hemoperfusion Production Market Competitive Situation and Trends
2.7.1 Hemoperfusion Production Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemoperfusion Production Players Market Share by Revenue
2.7.3 Global Hemoperfusion Production Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemoperfusion Production Retrospective Market Scenario by Region
3.1 Global Hemoperfusion Production Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemoperfusion Production Global Hemoperfusion Production Sales by Region: 2019-2030
3.2.1 Global Hemoperfusion Production Sales by Region: 2019-2024
3.2.2 Global Hemoperfusion Production Sales by Region: 2025-2030
3.3 Global Hemoperfusion Production Global Hemoperfusion Production Revenue by Region: 2019-2030
3.3.1 Global Hemoperfusion Production Revenue by Region: 2019-2024
3.3.2 Global Hemoperfusion Production Revenue by Region: 2025-2030
3.4 North America Hemoperfusion Production Market Facts & Figures by Country
3.4.1 North America Hemoperfusion Production Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemoperfusion Production Sales by Country (2019-2030)
3.4.3 North America Hemoperfusion Production Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemoperfusion Production Market Facts & Figures by Country
3.5.1 Europe Hemoperfusion Production Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemoperfusion Production Sales by Country (2019-2030)
3.5.3 Europe Hemoperfusion Production Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemoperfusion Production Market Facts & Figures by Country
3.6.1 Asia Pacific Hemoperfusion Production Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemoperfusion Production Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemoperfusion Production Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemoperfusion Production Market Facts & Figures by Country
3.7.1 Latin America Hemoperfusion Production Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemoperfusion Production Sales by Country (2019-2030)
3.7.3 Latin America Hemoperfusion Production Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemoperfusion Production Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemoperfusion Production Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemoperfusion Production Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemoperfusion Production Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemoperfusion Production Sales by Type (2019-2030)
4.1.1 Global Hemoperfusion Production Sales by Type (2019-2024)
4.1.2 Global Hemoperfusion Production Sales by Type (2025-2030)
4.1.3 Global Hemoperfusion Production Sales Market Share by Type (2019-2030)
4.2 Global Hemoperfusion Production Revenue by Type (2019-2030)
4.2.1 Global Hemoperfusion Production Revenue by Type (2019-2024)
4.2.2 Global Hemoperfusion Production Revenue by Type (2025-2030)
4.2.3 Global Hemoperfusion Production Revenue Market Share by Type (2019-2030)
4.3 Global Hemoperfusion Production Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemoperfusion Production Sales by Application (2019-2030)
5.1.1 Global Hemoperfusion Production Sales by Application (2019-2024)
5.1.2 Global Hemoperfusion Production Sales by Application (2025-2030)
5.1.3 Global Hemoperfusion Production Sales Market Share by Application (2019-2030)
5.2 Global Hemoperfusion Production Revenue by Application (2019-2030)
5.2.1 Global Hemoperfusion Production Revenue by Application (2019-2024)
5.2.2 Global Hemoperfusion Production Revenue by Application (2025-2030)
5.2.3 Global Hemoperfusion Production Revenue Market Share by Application (2019-2030)
5.3 Global Hemoperfusion Production Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Jafron Biomedical
6.1.1 Jafron Biomedical Corporation Information
6.1.2 Jafron Biomedical Description and Business Overview
6.1.3 Jafron Biomedical Hemoperfusion Production Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Jafron Biomedical Hemoperfusion Production Product Portfolio
6.1.5 Jafron Biomedical Recent Developments/Updates
6.2 Baxter (Gambro)
6.2.1 Baxter (Gambro) Corporation Information
6.2.2 Baxter (Gambro) Description and Business Overview
6.2.3 Baxter (Gambro) Hemoperfusion Production Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter (Gambro) Hemoperfusion Production Product Portfolio
6.2.5 Baxter (Gambro) Recent Developments/Updates
6.3 Biosun Medical
6.3.1 Biosun Medical Corporation Information
6.3.2 Biosun Medical Description and Business Overview
6.3.3 Biosun Medical Hemoperfusion Production Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biosun Medical Hemoperfusion Production Product Portfolio
6.3.5 Biosun Medical Recent Developments/Updates
6.4 Toray Medical
6.4.1 Toray Medical Corporation Information
6.4.2 Toray Medical Description and Business Overview
6.4.3 Toray Medical Hemoperfusion Production Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Toray Medical Hemoperfusion Production Product Portfolio
6.4.5 Toray Medical Recent Developments/Updates
6.5 Asahi-Kasei
6.5.1 Asahi-Kasei Corporation Information
6.5.2 Asahi-Kasei Description and Business Overview
6.5.3 Asahi-Kasei Hemoperfusion Production Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Asahi-Kasei Hemoperfusion Production Product Portfolio
6.5.5 Asahi-Kasei Recent Developments/Updates
6.6 Kaneka
6.6.1 Kaneka Corporation Information
6.6.2 Kaneka Description and Business Overview
6.6.3 Kaneka Hemoperfusion Production Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kaneka Hemoperfusion Production Product Portfolio
6.6.5 Kaneka Recent Developments/Updates
6.7 Zibo Kangbei
6.6.1 Zibo Kangbei Corporation Information
6.6.2 Zibo Kangbei Description and Business Overview
6.6.3 Zibo Kangbei Hemoperfusion Production Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zibo Kangbei Hemoperfusion Production Product Portfolio
6.7.5 Zibo Kangbei Recent Developments/Updates
6.8 Aier
6.8.1 Aier Corporation Information
6.8.2 Aier Description and Business Overview
6.8.3 Aier Hemoperfusion Production Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aier Hemoperfusion Production Product Portfolio
6.8.5 Aier Recent Developments/Updates
6.9 Cytosorbents
6.9.1 Cytosorbents Corporation Information
6.9.2 Cytosorbents Description and Business Overview
6.9.3 Cytosorbents Hemoperfusion Production Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cytosorbents Hemoperfusion Production Product Portfolio
6.9.5 Cytosorbents Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemoperfusion Production Industry Chain Analysis
7.2 Hemoperfusion Production Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemoperfusion Production Production Mode & Process
7.4 Hemoperfusion Production Sales and Marketing
7.4.1 Hemoperfusion Production Sales Channels
7.4.2 Hemoperfusion Production Distributors
7.5 Hemoperfusion Production Customers
8 Hemoperfusion Production Market Dynamics
8.1 Hemoperfusion Production Industry Trends
8.2 Hemoperfusion Production Market Drivers
8.3 Hemoperfusion Production Market Challenges
8.4 Hemoperfusion Production Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
